Showing posts with label Multiple Sclerosis Guidelines. Show all posts
Showing posts with label Multiple Sclerosis Guidelines. Show all posts

Saturday, March 2, 2013

// // Leave a Comment

Multiple Sclerosis Guidelines 2013

 Multiple Sclerosis is the most common neurological disease that causes disability in young adults. Over 2,500,000 people worldwide are diagnosed with MS. Over 100,000 of whom live in the UK. Due to recent studies it is known that women are twice more affected than men.

- Multiple Sclerosis is a demyelinating disease can be extended to the entire nervous system.

- The cause of Multiple Sclerosis is unknown until now. It could be a genetic factor involved, because the risk of Multiple Sclerosis in a person is slightly increased if one parent has multiple sclerosis. Now, not always obvious, a person's geographic location during childhood and the risk of developing multiple sclerosis later in life, suggests that it may be involved some environmental factors such as viral infections or other infectious diseases.

-Onset Multiple Sclerosis usually registers between 20 and 40 years, with a latency period of 10-20 years.

-Although both brain and spinal cord were macroscopically normal appearance in patients with multiple sclerosis, level sections, are found certain areas called plaques corresponding to demyelination process and have an gray-pink aspect.
Multiple Sclerosis Guidelines 2013

-Symptoms of Multiple Sclerosis vary from person to person, depending on what part of the brain or spinal cord (central nervous system) is affected. Multiple sclerosis is manifested by narrowing of visual field and subsequently and corresponding fundus examination, double vision or strabismus, dizziness, balance disorders, hemiplegia, hemiparesis, flaccid paraplegia or spasmodic, sexual dysfunction, memory loss, difficulty in concentration, decreased attention and difficulty in finding adequate words, depression, anxiety and anger, a rare symptom is excessive cheerfulness that seems inappropriate.

-Treatment of Multiple Sclerosis currently includes anti-inflammatory and   immunosuppressive drugs. In anti-inflammatory treatment, corticosteroid therapy is the most common form of treatment for Multiple Sclerosis and is based on methylprednisolone or prednisone. Immunosuppressive treatment includes azathioprine or cyclophosphamide. Motor rehabilitation and physiotherapy can be useful between spikes.

-In general, currently Multiple Sclerosis or episodes of the disease can not be prevent. In people who have Multiple Sclerosis Relapse-Remitting type, treatment with interferon beta or glatiramer acetate may reduce the frequency of relapses and interferon beta can delay development of disability.

-Multiple Sclerosis patients should follow some useful advice's -if it is possible, they need to were physically and intellectually active, exciting to organize their time and to conserve energy, to establish their priorities, learn and practice relaxation exercises, to maintain a sense of humor and to establish realistic goals.

Multiple Sclerosis is a debilitating disease that stigmatizes young life, but fair and early treatment can relieve the suffering of these patients!

Read More